NEUP Neuphoria Therapeutics Inc.
$3.39▲ +0.30%
Healthcare
Other
Volume 3.6K
Avg Volume (10D) 33.9K
Key Metrics & Fundamentals
Market Cap
$18.34M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.19 - 5.53
% vs 50 MA
-6.43%
% vs 200 MA
-18.85%
RSI-14
42.6
MACD Histogram
+0.0200
Beta (1Y vs SPY)
0.91
Free Cash Flow
$1.21M
Gross Rev
$1.17M
Gross Profit
$1.17M
EBITDA
$4.91M
COGS
–
Operating Exp
$1.36M
Operating Income
-$183,921
EBIT
-$183,921
Pretax Income
-$4.94M
Net Income
-$4.90M
Price & Volume History
Loading chart…
Recent News
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
Proactive · Oct 9, 2026 2:45 AM ET
Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development
GlobeNewswire · Sep 24, 2026 1:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NEUP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.